참고문헌
- Ahn K, Johnson DS, Fitzgerald LR, Liimatta M, Arendse A, Stevenson T, Lund ET, Nugent RA, Nomanbhoy TK, Alexander JP, Cravatt BF. Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity. Biochemistry 2007. 46: 13019-13030. https://doi.org/10.1021/bi701378g
- Bisogno T, Ligresti A, Di Marzo V. The endocannabinoid signalling system: biochemical aspects. Pharmacol Biochem Behav. 2005.81: 224-238. https://doi.org/10.1016/j.pbb.2005.01.027
- Boldrup L, Wilson SJ, Barbier AJ, Fowler CJ A simple stopped assay for fatty acid amide hydrolase avoiding the use of a chloroform extraction phase. J Biochem Biophys Methods. 2004: 60:171-177. https://doi.org/10.1016/j.jbbm.2004.04.020
- Bracey MH, Hanson MA, Masuda KR, Stevens RC, Cravatt BF. Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science 2002. 298: 1793-1796. https://doi.org/10.1126/science.1076535
- Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 1996. 384: 83-87. https://doi.org/10.1038/384083a0
- Cravatt BF, Saghatelian A, Hawkins EG, Clement AB, Bracey MH, Lichtman AH. Functional disassociation of the central and peripheral fatty acid amide signaling systems. Proc Natl Acad Sci USA. 2004. 101: 10821-10826. https://doi.org/10.1073/pnas.0401292101
- De Bank PA, Kendall DA, Alexander SP. A spectrophotometric assay for tatty acid amide hydrolase suitable for high-throughput screening. Biochem Pharmacol. 2005. 69: 1187-1193. https://doi.org/10.1016/j.bcp.2005.01.012
- Deutsch DG, Chin SA. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol. 1993.46: 791-796. https://doi.org/10.1016/0006-2952(93)90486-G
- Ghil S, Choi JM, Kim SS, Lee YD, Liao Y, Bimbaumer L, Suh-Kim H. Compartmentalization of protein kinase A signaling by the heterotrimeric G protein Go. Proc Natl Acad Sci USA. 2006.103: 19158-19163. https://doi.org/10.1073/pnas.0609392103
- Hohmann AG, Suplita RL. Endocannabinoid mechanisms of pain modulation. AAPS J. 2006. 8: E693-708. https://doi.org/10.1208/aapsj080479
- Jayamanne A, Greenwood R, Mitchell VA, AsIan S, Piomelli D, Vaughan CW. Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models. Br J Pharmacol. 2006. 147: 281-288. https://doi.org/10.1038/sj.bjp.0706510
- Labar G, Michaux C. Fatty acid amide hydrolase: from characterization to therapeutics. Chem Biodivers. 2007. 4: 1882-1902. https://doi.org/10.1002/cbdv.200790157
- Maccarrone M, Bari M, Agro AF. A sensitive and specific radiochromatographic assay of fatty acid amide hydrolase activity. Anal Biochem. 1999.267: 314-318. https://doi.org/10.1006/abio.1998.2964
- Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990. 346: 561-564. https://doi.org/10.1038/346561a0
- Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993. 365: 61-65. https://doi.org/10.1038/365061a0
- Omeir RL, Chin S, Hong Y, Ahem DG, Deutsch DG. Arachidonoyl ethanolamide-[1,2-14C] as a substrate for anandamide amidase. Life Sci. 1995.56: 1999-2005. https://doi.org/10.1016/0024-3205(95)00181-5
- Patricelli MP, Cravatt BF. Characterization and manipulation of the acyl chain selectivity of fatty acid amide hydrolase. Biochemistry 2001. 40: 6107-6115. https://doi.org/10.1021/bi002578r
- Ramarao MK, Murphy EA, Shen MW, Wang Y, Bushell KN, Huang N, Pan N, Williams C, Clark JD. A fluorescence-based assay for fatty acid amide hydrolase compatible with high-throughput screening. Anal Biochem. 2005. 343: 143-151. https://doi.org/10.1016/j.ab.2005.04.032
- Timmons A, Seierstad M, Apodaca R, Epperson M, Pippel D, Brown S, Chang L, Scott B, Webb M, Chaplan SR, Breitenbucher JG. Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH). Bioorg Med Chem Lett. 2008. 18: 2109-2113. https://doi.org/10.1016/j.bmcl.2008.01.091
- Ueda N, Puffenbarger RA, Yamamoto S, Deutsch DG. The fatty acid amide hydrolase (FAAH). Chern Phys Lipids. 2000. 108:107-121. https://doi.org/10.1016/S0009-3084(00)00190-0
- Wilson SJ, Lovenberg TW, Barbier AJ. A high-throughput-compatible assay for determining the activity of fatty acid amide hydrolase. Anal Biochem. 2003. 318: 270-275. https://doi.org/10.1016/S0003-2697(03)00217-3
- Zhang D, Saraf A, Kolasa T, Bhatia P, Zheng GZ, Patel M, Lannoye GS, Richardson P, Stewart A, Rogers JC, Brioni JD, Surowy CS. Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets. Neuropharmacology 2007. 52: 1095-1105. https://doi.org/10.1016/j.neuropharm.2006.11.009